Skip to content

Goodwill at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$47.1M-83.5%
Azenta logo
AzentaAZTA
$553.07M
Quest Diagnostics logo
Quest DiagnosticsDGX
$9.12B+3.1%
NeoGenomics logo
NeoGenomicsNEO
$524M+0.2%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$3.04B+5.8%
Castle Biosciences logo
Castle BiosciencesCSTL
$10.7M0.0%

Segments

By segment

See full
Diagnostics$5.61B
Biopharma Laboratory Services$1.35B

Other financials

Income statement

See full
Revenue$3.5B+5.8%
Gross profit$1.0B+6.9%
Operating income$380.8M+16.8%
Net income$277.8M+30.5%
EPS (diluted)$3.35+32.9%

Balance sheet

See full
Cash & equivalents$981.1M+166%
Total debt$7.2B+11.1%
Total equity$8.7B+5.1%
Total assets$19.1B+8.4%

Cash flow

See full
Operating cash flow$191.5M+935%
CapEx$121.0M-4.0%
Free cash flow$70.5M+166%

Valuation

See full
Market cap$22.96B+9.4%
Enterprise value$29.22B+10.7%
P/E24.4×-3.1×
P/S1.6×+0.1×

Profitability

See full
Gross margin28.8%+0.9pp
Operating margin10.2%+1.9pp
Net margin6.7%+1.1pp
FCF margin9.8%+1.0pp

Returns & leverage

See full
Return on equity11.1%+2.1pp
Debt / equity0.8×0.0×
Current ratio1.7×-0.1×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Labcorp Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Labcorp Holdings's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Labcorp Holdings's goodwill?
Labcorp Holdings (LH) reported goodwill of $6.96B in Q1 2026.
How has Labcorp Holdings's goodwill changed year-over-year?
Labcorp Holdings's goodwill increased by 8.3% year-over-year, from $6.42B to $6.96B.
What is the long-term trend for Labcorp Holdings's goodwill?
Over 5 years (2020 to 2025), Labcorp Holdings's goodwill has grown at a -2.6% compound annual growth rate (CAGR), from $7.75B to $6.79B.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.